UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| 1 |
Alibaba
BABA
|
+$2.55B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$459M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$316M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$293M |
| 5 |
GSK
GSK
|
+$251M |
Top Sells
| 1 |
Stellantis
STLA
|
+$991M |
| 2 |
Microsoft
MSFT
|
+$408M |
| 3 |
Apple
AAPL
|
+$315M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$296M |
| 5 |
Intel
INTC
|
+$283M |
Sector Composition
| 1 | Technology | 14.92% |
| 2 | Consumer Discretionary | 9.1% |
| 3 | Financials | 8.49% |
| 4 | Healthcare | 7.86% |
| 5 | Industrials | 6.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3351
Montrose Environmental
MEG
$1.04B
| $1M | ﹤0.01% |
19,984
+2,370
| +13% | +$119K |
|
3352
Q2 Holdings
QTWO
$5.26B
| $1M | ﹤0.01% |
10,000
+4,284
| +75% | +$429K |
|
|
INVX
3353
Innovex International, Inc.
INVX
$1.18B
| $1M | ﹤0.01% |
30,139
+29,814
| +9,174% | +$991K |
|
3354
AngioDynamics
ANGO
$447M
| $1M | ﹤0.01% |
42,731
-4,343
| -9% | -$102K |
|
|
FRTA
3355
DELISTED
Forterra, Inc
FRTA
| $1M | ﹤0.01% |
43,009
+10,880
| +34% | +$253K |
|
|
JHMH
3356
DELISTED
John Hancock Multifactor Healthcare ETF
JHMH
| $999K | ﹤0.01% |
22,456
+339
| +2% | +$15.1K |
|
|
ADAP
3357
Adaptimmune Therapeutics
ADAP
$42.4M
| $998K | ﹤0.01% |
188,084
+6,502
| +4% | +$34.5K |
|
3358
Anavex Life Sciences
AVXL
$745M
| $995K | ﹤0.01% |
66,604
+51,693
| +347% | +$772K |
|
3359
BJ's Restaurants
BJRI
$663M
| $994K | ﹤0.01% |
17,127
-848
| -5% | -$49.2K |
|
|
MOON
3360
DELISTED
Direxion Moonshot Innovators ETF
MOON
| $993K | ﹤0.01% |
24,195
-25,805
| -52% | -$1.06M |
|
|
EHI
3361
Western Asset Global High Income Fund
EHI
$201M
| $992K | ﹤0.01% |
94,537
-14,875
| -14% | -$156K |
|
3362
Sanmina
SANM
$6.36B
| $991K | ﹤0.01% |
23,954
-8,670
| -27% | -$359K |
|
3363
Corcept Therapeutics
CORT
$8.41B
| $989K | ﹤0.01% |
41,569
+621
| +2% | +$14.8K |
|
3364
Kymera Therapeutics
KYMR
$3.66B
| $989K | ﹤0.01% |
25,442
+21,829
| +604% | +$849K |
|
3365
Select Water Solutions
WTTR
$1.05B
| $989K | ﹤0.01% |
198,572
+1,763
| +0.9% | +$8.78K |
|
3366
Upstart Holdings
UPST
$6.55B
| $988K | ﹤0.01% |
7,673
+6,846
| +828% | +$882K |
|
3367
Costamare
CMRE
$1.53B
| $987K | ﹤0.01% |
102,581
+10,757
| +12% | +$104K |
|
|
ALBO
3368
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $987K | ﹤0.01% |
28,001
+27,911
| +31,012% | +$984K |
|
3369
Virtus Investment Partners
VRTS
$1.31B
| $986K | ﹤0.01% |
4,184
-889
| -18% | -$210K |
|
3370
STAAR Surgical
STAA
$1.34B
| $985K | ﹤0.01% |
9,349
-2,275
| -20% | -$240K |
|
|
ASG
3371
Liberty All-Star Growth Fund
ASG
$346M
| $984K | ﹤0.01% |
114,341
+1,113
| +1% | +$9.58K |
|
3372
US Physical Therapy
USPH
$1.22B
| $984K | ﹤0.01% |
9,449
+3,978
| +73% | +$414K |
|
3373
Central Pacific Financial
CPF
$846M
| $982K | ﹤0.01% |
36,780
-11,531
| -24% | -$308K |
|
|
EOT
3374
Eaton Vance National Municipal Opportunities Trust
EOT
$260M
| $978K | ﹤0.01% |
43,465
+2,099
| +5% | +$47.2K |
|
3375
Scholastic
SCHL
$691M
| $978K | ﹤0.01% |
32,491
+1,651
| +5% | +$49.7K |
|